Skip to main content
Accelerated metabolomic aging and its association with social determinants of health in multiple sclerosis.
Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis.
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.
Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis.
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease.
Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis.
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2.
Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis.
A new look at cognitive functioning in pediatric MS.